Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 15, 1998 - Issue 4
Submit an article Journal homepage
105
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Preparation and in vitro dissolution profile of dual polymer (Eudragit RS100 and RL100) microparticles of diltiazem hydrochloride

S. K. Das Nova Southeastern University, College of Pharmacy, 3200 South University Drive, Ft Lauderdale, FL, 33328, USA
&
N. G. Das University of Pittsburgh, School of Pharmacy, Pittsburgh, PA, 15261, USA
Pages 445-452 | Received 25 Aug 1996, Accepted 10 Sep 1997, Published online: 27 Sep 2008

References

  • Buxton I. R., Brown A., Critchley H., Leslie S. T., Malkowska A., Prater D. A., Miller R. B. European Patient Publication. #EP 527638 A1, 1993
  • Carmella C., Ferrari F., Bonferoni M. C., Sangalli M. E., De Bernardi di Velserra M., Feletti F., Galmozzi M. R. In vitro/in viwo correlation of prolonged release dosage forms containing diltiazem HCL. Biopharm. and Drug Disp. 1993; 14: 143–160
  • Chaffman M., Brogden R N. Diltiazem: A review of its pharmacological properties and therapeutic efficacy. Drugs 1985; 29: 387–454
  • Chang R. R., Pereira-Rosario R., Rudnic E. M. International Patent. #WO 90/016107, 1990
  • Cutler N. R., Eff J., Fromell G., Brass E. P., Archer S., Chrystant S. G., Fiddes R. Dose-ranging study of a new, once daily diltiazem formulation for patients with stable angina. J. Clin. Pharmacol. 1995; 35: 189–195
  • Fiddes R., Heym H., Hilty W., Lewin A. J., Codispoti J., McNally C., Stokes A., Gilderman L. Blood pressure control with diltiazem XR, a novel extended release formulation of diltiazem HCL, in mature and elderly hypertensive patients. Clin. Ther. 1994; 16: 209–212
  • Gordin A., Potho P., Sundberg S., Nykanen S., Haataja H., Mannisto P. Pharmacokinetics of slow-release diltiazem and its effect on atrioventricular conduction in healthy volunteers. Eur. J. Clin. Pharmacol. 1986; 31: 423–426
  • Hermann P., Roger S. D., Remones G., Thenot J. P., London D. R., Morselli P. L. Pharmacokinetics of diltiazem after intravenous and oral administration. Eur. J. Clin. Pharmacol. 1983; 24: 349–352
  • Janicki S., Jedras Z. Diltiazem multi-dose gastrointestinal diffusion system: Preparation and release rate studies. Il Farmaco 1989; 44: 531–539
  • Leeuwenkamp O. R., Visscher H. W., Mensick C. K., Jonkman J. H. A comparative study of the steady state pharmacokinetics of immediate release and controlled release diltiazem tablets. Eur. J. Clin. Pharmacol. 1994; 46: 243–247
  • Li S. P., Felt R. G., Di Paolo L. C., Huang M. Y., Williams R. O., III. Development and in vitro-in vivo evaluation of a multiparticulate sustained release formulation of diltiazem. Pharm. Res. 1995; 12: 1338–1342
  • Malamataris S., Avgerino A. Controlled release indomethacin microspheres prepared by using an emulsion solvent-diffusion technique. Int. J. Pharm. 1990; 62: 105–111
  • Markham A., Brogden R. N. Diltiazem: A review of its pharmacology and therapeutic use in older patients. Drugs and Aging 1993; 3: 363–390
  • Morella A. M., Fisher M. C. European Patent Publication. #EP 377518 A2, 1990
  • Murata K., Yamahara H., Kobayashi M., Noda K., Samejima M. Pharmacokinetics of an oral sustained release diltiazem preparation. J. Pharm. Sci. 1989; 78: 960–963
  • Okor R. S. Drug release on certain acrylate methacylate-salicylic acid coacervate systems. J, Control. Rel. 1990; 12: 195–200
  • Oth M. P., Moes A. J. Sustained release solid dispersions of indomethacin with Eudragit RS and RL. Int. J. Pharm. 1989; 55: 157–164
  • Pool P. E., Herron J. M., Rosenblatt S. Metabolic effects of antihypertensive therapy with a calcium antagonist. Am. J. Cardiol. 1988; 62: 109G–113G
  • Russell R. P. Side effects of calcium channel blockers. Hypertension 1988; 11(suppl II)1142–1144
  • Sangekar S., Vadino W. A., Cefali E. A. US Patent Publication. #5000962, 1991
  • Schwartz J. B., Abernethy D. R. Response to intravenous and oral diltiazem in elderly and younger patients with systemic hypertension. Am. J. Cardiol. 1987; 59: 1111–1117
  • Smith M. S., Verghese C. P., Shand D. G., Pritcgett E. L. C. Pharmacokinetics and pharmacodynamic effects of diltiazem. Am. J. Cardiol. 1983; 51: 1369–1374
  • Trimarco B., Radzik D., Van Mieghem W., Neveux E., Wajman A., Attall P., Ponsonnaille J. Efficacy and safety of the 200–300mg sustained released formulation of diltiazem administered once daily in patients with stable angina. Eur. J. Clin. Pharmacol. 1995; 47: 493–496
  • Uekama K., Hirashima N., Horiuichi Y., Hirayama F., Ijitsu T., Ueno M. Ethylated β-cyclodextrins as hydrophobic drug carriers: Sustained release of diltiazem in the rat. J. Pharm. Sci. 1987; 76: 660–661
  • Vasilevska K., Djuric Z., Jovanovic M., Simov A. Preparation and dissolution characterization of controlled release diltiazem pellets. Drug Dev. Ind. Pharm. 1992; 18: 1649–1661

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.